Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luisa M Rodriguez

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Children (Basel, Switzerland)|November 27, 2025
Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in ChildrenHussein Zaitoon, Aimee D Wauters, Luisa M Rodriguez, et al.
Children (Basel, Switzerland)|May 27, 2026
Reply to Improda, N.; Ballarin, G. Body Composition in Paediatric GLP-1 Receptor Agonist Therapy. Comment on "Zaitoon et al. Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children. <i>Children</i> 2025, <i>12</i>, 1427"Hussein Zaitoon, Aimee D Wauters, Luisa M Rodriguez, et al.
Diabetes|March 29, 2005
The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetesRubina A Heptulla, Luisa M Rodriguez, Lisa Bomgaars, et al.
Pediatric Diabetes|September 3, 2008
Gastric emptying and postprandial glucose excursions in adolescents with type 1 diabetesRubina A Heptulla, Luisa M Rodriguez, Kimberly J Mason, et al.
The Journal of Clinical Endocrinology and Metabolism|February 5, 2009
Twenty-four-hour simultaneous subcutaneous Basal-bolus administration of insulin and amylin in adolescents with type 1 diabetes decreases postprandial hyperglycemiaRubina A Heptulla, Luisa M Rodriguez, Kimberly J Mason, et al.
Pediatric Diabetes|July 31, 2007
Serum 1,5-anhydroglucitol (Glycomark) levels in children with and without type 1 diabetes mellitusThanh M Nguyen, Luisa M Rodriguez, Kimberly J Mason, et al.
Pediatric Research|October 25, 2007
The role of prandial pramlintide in the treatment of adolescents with type 1 diabetesLuisa M Rodriguez, Kimberly J Mason, Morey W Haymond, et al.
Pediatrics|February 27, 2008
A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetesKrishnavathana Hassan, Luisa M Rodriguez, Susan E Johnson, et al.
Diabetes Care|October 27, 2004
Effects of mixing glargine and short-acting insulin analogs on glucose controlWalid Kaplan, Luisa M Rodriguez, O'Brian E Smith, et al.
Journal of Diabetes & Metabolism|September 27, 2014
The Relationship between Self-Management and Glycemic Control in a Cohort of Children with Type 1 and Type 2 DiabetesLuisa M Rodriguez, Krishnavathana V Hassan, Jeffrey Rhodes, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Children (Basel, Switzerland)|November 27, 2025
Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in ChildrenHussein Zaitoon, Aimee D Wauters, Luisa M Rodriguez, et al.
Children (Basel, Switzerland)|May 27, 2026
Reply to Improda, N.; Ballarin, G. Body Composition in Paediatric GLP-1 Receptor Agonist Therapy. Comment on "Zaitoon et al. Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children. <i>Children</i> 2025, <i>12</i>, 1427"Hussein Zaitoon, Aimee D Wauters, Luisa M Rodriguez, et al.
Diabetes|March 29, 2005
The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetesRubina A Heptulla, Luisa M Rodriguez, Lisa Bomgaars, et al.
Pediatric Diabetes|September 3, 2008
Gastric emptying and postprandial glucose excursions in adolescents with type 1 diabetesRubina A Heptulla, Luisa M Rodriguez, Kimberly J Mason, et al.
The Journal of Clinical Endocrinology and Metabolism|February 5, 2009
Twenty-four-hour simultaneous subcutaneous Basal-bolus administration of insulin and amylin in adolescents with type 1 diabetes decreases postprandial hyperglycemiaRubina A Heptulla, Luisa M Rodriguez, Kimberly J Mason, et al.
Pediatric Diabetes|July 31, 2007
Serum 1,5-anhydroglucitol (Glycomark) levels in children with and without type 1 diabetes mellitusThanh M Nguyen, Luisa M Rodriguez, Kimberly J Mason, et al.
Pediatric Research|October 25, 2007
The role of prandial pramlintide in the treatment of adolescents with type 1 diabetesLuisa M Rodriguez, Kimberly J Mason, Morey W Haymond, et al.
Pediatrics|February 27, 2008
A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetesKrishnavathana Hassan, Luisa M Rodriguez, Susan E Johnson, et al.
Diabetes Care|October 27, 2004
Effects of mixing glargine and short-acting insulin analogs on glucose controlWalid Kaplan, Luisa M Rodriguez, O'Brian E Smith, et al.
Journal of Diabetes & Metabolism|September 27, 2014
The Relationship between Self-Management and Glycemic Control in a Cohort of Children with Type 1 and Type 2 DiabetesLuisa M Rodriguez, Krishnavathana V Hassan, Jeffrey Rhodes, et al.
Pageof 3